Gastro Medical News about Crohn's disease

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New biologics in the management of Crohn's disease: focus on certolizumab pegol
Clinical and Experimental Gastroenterology, 06/25/09

Colombo E et al. - Crohn's disease (CD) is a chronic inflammatory condition involving the gastrointestinal tract characterized by recurrent exacerbations and remission. The disease frequently occurs in the lower part of the small bowel, but can affect any part of the digestive tract, from the mouth to the anus. This review focuses on certolizumab pegol, the first Fc-free PEGylated Fab' fragment of humanized monoclonal antibody that binds and neutralizes human tumor necrosis factor alpha.

<< Previous
Osteoporosis in Inflammatory Bowel Disease

Next >>
Pellagra associated with esophageal carcinoma and alcoholism

A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09 Relevance Score: 69%

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09 Relevance Score: 68%

Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09 Relevance Score: 68%

Bowel Disease Treatment May Raise Skin Cancer Risk
MedLinePlus, 10/28/09 Relevance Score: 68%

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09 Relevance Score: 68%